Steinert Myotonic Dystrophy

By Dr. Carlos Rocha de Lossada / MD PhD

Project aim

Myotonic dystrophy is an autosomal dominant inherited muscle disease that affects approximately 1 in every 8000 people. In some studies the characteristics of the cornea in these patients have been studied to assess whether variations are observed with respect to the healthy population and whether these justify the hypotonia they present.

In other studies, a relationship between myotonic dystrophy and Fuchs’s endothelial corneal dystrophy has been proposed. In our study we are studying the biomechanical and morphological properties of the cornea, as well as the characteristics of the endothelium of patients with myotonic dystrophy. In the current literature there is nothing published about the metagenomics of the ocular surface microbiome of patients with myotonic dystrophy.

Execution

To investigate the myotonic dystrophy associated ocular microbiome we are going to use 25 conjunctival swabs obtained from patients diagnosed with myotonic dystrophy. Written informed consent will be obtained from all patients.


Project Manager
Dr. Carlos Rocha de Lossada / MD PhD

Supervisor
Dr. Borroni Davide / MD PhD

Date
30/11/2021

Funding partners
Eyemetagenomics Ltd

Published on

Tagged in: Project

🇬🇧
🇮🇹
🇪🇸
Eyemetagenomics Ltd
71-75 Shelton Street, Covent Garden
London WC2H 9JQ, ENGLAND
LUCY does not claim to diagnose, treat, cure, or prevent any disease. The information on the LUCY website is provided for informational purposes only and with the understanding that LUCY is not engaged in rendering medical advice or recommendations. You should not rely on any information on the website to diagnose or treat a health problem or condition or replace consultations with qualified health care professionals to meet your individual needs. Always check with your doctor for answers to your personal medical questions.

Copyright © 2024 Eyemetagenomics Ltd. All rights reserved.
Cookie Policy